Apoptosis and estrogen deficiency in primary Sjögren syndrome

Current Opinion in Rheumatology

Volumn 16, Issue 5, 2004, Pages 522-526

  Hayashi, Yoshio ^a   Arakaki, Rieko ^a   Ishimaru, Naozumi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Activation induced cell death; Apoptosis; Estrogen deficiency; Sj gren syndrome

Indexed keywords

ASPARTYLGLUTAMINYLVALYLASPARTIC ACID ALDEHYDE; AUTOANTIGEN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; EPITOPE; FAS ANTIGEN; FAS LIGAND; FODRIN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL CLONING; CELL DEATH; CELL PROLIFERATION; CYTOTOXICITY; EFFECTOR CELL; ESTROGEN DEFICIENCY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SJOEGREN SYNDROME; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; ESTROGENS; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 4344609041     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000135450.78047.78     Document Type: Review

References (58)

1. Miller JF: Self-nonself discrimination and tolerance in T and B lymphocytes. Immunol Res 1993, 12:115-130.
2. Yan J, Mamula MJ: Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J Immunol 2002, 168:3188-3194.
3. Fox RI, Stern M, Michelson P: Update in Sjögren's syndrome. Curr Opin Rheumatol 2000, 12:391-398.
4. Manoussakis MN, Moutsopoulos HM: Sjögren's syndrome: current concepts. Adv Intern Med 2001, 47:191-217.
5. Chan EK, Hamel JC, Buyon JP, et al.: Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991, 87:68-76.
6. Bieganowska KD, Ausubel LJ, Modabber Y, et al.: Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. J Exp Med 1997, 185:1585-1594.
7. Casciola-Rosen L, Rosen A, Petri M, et al.: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996, 93:1624-1629.
8. Miranda-Carus ME, Askanase AD, Clancy RM, et al.: Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000, 165:5345-5351.
9. Utz PJ, Hottelet M, Schur PH, et al.: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843-854.
10. Humpherys-Beher MG, Peck AB, Dang H, et al.: The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome. Clin Exp Immunol 1999, 116:383-387.
11. Ito M, Terasaki S, Itoh J, et al.: Rheumatic disease in an MRL strain of mice with a deficit in functional Fas ligand. Arthritis Rheum 1997, 40:1054-1063.
12. Nishio A, Katakai T, Oshima C, et al.: A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 1996, 111:956-967.
13. Giordano C, Stassi G, De Maria R, et al.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997, 275:960-963.
14. Apostolou I, Hao Z, Rajewsky K: et al.: Effective destruction of Fas-deficient insulin-producing β cells in type I diabetes. J Exp Med 2003, 198:1103-1106.
15. Silva DG, Socha L, Charlton B, et al.: Autoimmune diabetes in the NOD mouse: an essential role of Fas-FasL signaling in β cell apoptosis. Ann NY Acad Sci 2003, 1005:161-165. The study demonstrated that, in the presence of an inflammatory infiltrate, FasL-expressing β cells are exquisitely sensitive to Fas-mediated apoptosis and that this can be blocked by preventing FasL-Fas interaction.
16. Kong L, Ogawa N, Nakabayashi T, et al.: Fas and Fas ligand expression in salivary glands of patients with primary Sjögren syndrome. Arthritis Rheum 1997, 40:87-97.
17. Haneji N, Nakamura T, Takio K, et al.: Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997, 276:604-607.
18. Leto TL, Pleasic S, Forget BG, et al.: Characterization of the calmodulin-binding site of nonerythroid α-spectrin. J Biol Chem 1989, 264:5826-5830.
19. Martin SD, Finucane DM, Amarante-Mendes GP, et al.: Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 1996, 271:28753-28753.
20. Vanags DM, Pörn-Ares I, Coppolaa S, et al: Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996, 271:31075-31085.
21. Janicke RU, Sprengart ML, Porter AG: Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 1998, 273:15540-15545.
22. Nagaraju K, Cox A, Caciola-Rosen L, et al.: Novel fragments of the Sjögren's syndrome autoantigens α-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule- induced cell death. Arthritis Rheum 2001, 44:2376-2386.
23. Saegusa K, Ishimaru N, Yanagi K, et al.: Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome. J Immunol 2002, 169:1050-1057.
24. Hahn S, Gehri R, Erb P: Mechanism and biological significance of CD4- mediated cytotoxicity. Immunol Rev 1995, 146:57-79.
25. Rudel T, Bokoch GM: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997, 276:1571-1574.
26. Huang S, Jiang Y, Li Z, et al.: Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6β. Immunity 1997, 6:739.
27. Tewan M, Quan LT, O'Rouker K, et al.: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995, 81:801-809.
28. Casciola-Rosen L, Nicholson DW, Chong T, et al.: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996, 183:1957-1964.
29. Brunner T, Mogil RJ, LaFace D, et al.: Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995, 373:441-444.
30. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
31. Xu L, Zhang L, Kang HK, et al: Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med [serial online] 2004, doi: 10.1038/nm1005. Recent article demonstrates that activated T cells of lupus patients resist anergy and apoptosis by markedly upregulating and sustaining cyclooxygenase-2 (COX-21 expression. Studies with COX-2 inhibitors and Cox-2-deficient mice confirmed that this COX-2/FLIP antiapoptosis program is used selectively by anergy-resistant lupus T cells. It was also found that only COX-2 inhibitors were able to suppress the production of pathogenic autoantibodies to DNA by causing autoimmune T cell apoptosis.
32. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL-lpr/lpr. Proc Natl Acad Sci USA 1993, 90:10340-10344.
33. Ishimaru N, Yanagi K, Ogawa K, et al.: Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death (AICD) in murine Sjögren's syndrome. J Immunol 2001, 167:6031-6037.
34. Kabelitz D, Oberg H-H, Pohl T, et al.: Antigen-induced death of mature T lymphocytes: analysis by flow cytometry. Immunol Rev 1994, 142:157-174.
35. Pelfrey CM, Tranquill LR, Boehme SA, et al.: Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J Immunol 1995, 154:6191-6202.
36. Fisher GH, Rosenberg FJ, Strauss SE, et al.: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995, 81:935-946.
37. Finnegan A, Mikecz K, Tao P, et al.: Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999, 163:5383-5390.
38. Lahita RG: Sex steroids and the rheumatic diseases. Arthritis Rheum 1985, 28:121-126.
39. Bateman A, Singh A, Krai T: The immune-hypothalamic-pituitary-adrenal axis. Endocrinol Rev 1989, 10:92-112.
40. Lahita RG, Bradlow L, Fishman J, et al.: Estrogen metabolism in systemic lupus erythematosus: patients and family members. Arthritis Rheum 1982, 25:843-846.
41. Daniels T, Whitcher JP: Association of patients of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994, 37:869-877.
42. Ishimi Y, Miyaura C, Ohmura M, et al.: Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999, 140:1893-1900.
43. Masuzawa T, Miyaura C, Onoe Y, et al.: Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994, 94:1090-1097.
44. Mor G, Sapi E, Abrahams VM, et al.: Interaction of the estrogen receptors with the Fas ligand promotor in human monocytes. J Immunol 2003, 170:114-122.
45. Ishimaru N, Saegusa K, Yanagi K, et al.: Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through Fas-mediated apoptosis. Am J Pathol 1999, 155:173-181.
46. Fox HS, Bond BL, Parslow TG: Estrogen regulates the IFN-γ promoter. J Immunol 1991, 146:4362-4367.
47. Takabayashi H, Oida H, Fujisawa K, et al.: Hormone-induced apoptosis by Fas-nuclear receptor fusion protein: novel biological tools for controlling apoptosis in vivo. Cancer Res 1996, 56:4164-4170.
48. Spyridopoulos I, Sullivan A, Kearney M, et al.: Estrogen-receptor- mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997, 95:1505-1514.
49. Pelzer T, Schumann M, Neumann M, et al.: 17β-Estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun 2000, 268:192-200.
50. Ansar-Ahmed S, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985, 121:531-551.
51. + B cells to produce autoantibodies. J Immunol 1989, 142:2647-2653.
52. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 1999, 283:1277-1278.
53. Kimble RB, Srivastava S, Ross FP, et al.: Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 1996, 271:28890-28897.
54. Ishimaru N, Arakaki R, Watanabe M, et al.: Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol 2003, 163:1481-1490. This study evaluated the effects on autoantigen cleavage in estrogen-deficient healthy C57BL/6 (B6) mice treated with an ovariectomy. A significant increase in apoptotic epithelial salivary gland cells was associated with α-fodrin cleavage. A cleavage product of 120-kDa α-fodrin was detected in salivary gland cells that had undergone tamoxifen-induced apoptosis through caspase activation, especially caspase-1. Adoptive transfer of α-fodrin-reactive T cells into ovariectomized B6 mice resulted in the development of autoimmune exocrinopathy quite similar to Sjögren syndrome.
55. Morkuniene R, Jekabsone A, Borutaite V: Estrogens prevents calcium-induced release of cytochrome c from heart mitochondria. FEBS Lett 2002, 521:53-56.
56. Feinstein E, Kimchi A, Wallach D, et al.: The death domain: a module shared by proteins with diverse cellular function. Trends Biochem Sci 1995, 20:342-344.
57. Ozkan ED, Lee FS, Ueda T: A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc Natl Acad Sci USA 1997, 94:4137-4142.
58. Brown MJ, Hallam JA, Yamada KM, et al.: Integration of human T lymphocyte cytoskeleton by cytolinker protein. J Immunol 2001, 167:641-645.